SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-244975
Filing Date
2019-09-13
Accepted
2019-09-13 17:28:56
Documents
5
Period of Report
2019-09-13

Document Format Files

Seq Description Document Type Size
1 6-K d780493d6k.htm 6-K 12182
2 EX-99.1 d780493dex991.htm EX-99.1 190990
3 EX-99.2 d780493dex992.htm EX-99.2 13043
4 EX-99.3 d780493dex993.htm EX-99.3 8261
5 GRAPHIC g780493logo.jpg GRAPHIC 3526
  Complete submission text file 0001193125-19-244975.txt   230474
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 191093280
SIC: 2834 Pharmaceutical Preparations